Fragile X Syndrome: Scientific Background and Screening Technologies

Justine I Lyons1, Gregory R Kerr1, Patricia W Mueller1

  • 1Molecular Risk Assessment Laboratory, Newborn Screening and Molecular Biology Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.

Summary

Fragile X syndrome, a common inherited cause of intellectual disability, is increasingly screened using novel molecular technologies. This review compares three methods for detecting CGG-repeat expansions in males and females.